Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 22:3:145.
doi: 10.3389/fneur.2012.00145. eCollection 2012.

Putative role of prostaglandin receptor in intracerebral hemorrhage

Shekher Mohan  1 , Abdullah S Ahmad, Alexander V Glushakov, Chase Chambers, Sylvain Doré
Affiliations

Putative role of prostaglandin receptor in intracerebral hemorrhage

Shekher Mohan et al. Front Neurol. .

Abstract

Each year, approximately 795,000 people experience a new or recurrent stroke. Of all strokes, 84% are ischemic, 13% are intracerebral hemorrhage (ICH) strokes, and 3% are subarachnoid hemorrhage strokes. Despite the decreased incidence of ischemic stroke, there has been no change in the incidence of hemorrhagic stroke in the last decade. ICH is a devastating disease 37-38% of patients between the ages of 45 and 64 die within 30 days. In an effort to prevent ischemic and hemorrhagic strokes we and others have been studying the role of prostaglandins and their receptors. Prostaglandins are bioactive lipids derived from the metabolism of arachidonic acid. They sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Most prostaglandins are produced from specific enzymes and act upon cells via distinct G-protein coupled receptors. The presence of multiple prostaglandin receptors cross-reactivity and coupling to different signal transduction pathways allow differentiated cells to respond to prostaglandins in a unique manner. Due to the number of prostaglandin receptors, prostaglandin-dependent signaling can function either to promote neuronal survival or injury following acute excitotoxicity, hypoxia, and stress induced by ICH. To better understand the mechanisms of neuronal survival and neurotoxicity mediated by prostaglandin receptors, it is essential to understand downstream signaling. Several groups including ours have discovered unique roles for prostaglandin receptors in rodent models of ischemic stroke, excitotoxicity, and Alzheimer disease, highlighting the emerging role of prostaglandin receptor signaling in hemorrhagic stroke with a focus on cyclic-adenosine monophosphate and calcium (Ca(2+)) signaling. We review current ICH data and discuss future directions notably on prostaglandin receptors, which may lead to the development of unique therapeutic targets against hemorrhagic stroke and brain injuries alike.

Keywords: GPCR; brain; inflammation; neurodegenerative diseases; stroke; therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Phylogenetic tree of human (h) and mouse (m) EP1, EP2, EP3, EP4, FP, IP, TP, DP1, and DP2 (CRTH2) receptors. Tree was constructed using pairwise sequence alignment determined using CLUSTALW 2.1 Multiple sequence alignment software and presented as NJplot. Evolutionally conserved prostaglandin receptors can be grouped into signaling pathways: cAMP stimulating and calcium signaling.
Figure 2
Figure 2
Signal transduction mechanisms of activated prostaglandin receptors. Prostaglandin receptors have been grouped into specific G-protein-dependent cAMP and/or Ca2+ signaling.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abe T., Kunz A., Shimamura M., Zhou P., Anrather J., Iadecola C. (2009). The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic. J. Cereb. Blood Flow Metab. 29, 66–7210.1038/jcbfm.2008.88 - DOI - PMC - PubMed
    1. Abramovitz M., Boie Y., Nguyen T., Rushmore T. H., Bayne M. A., Metters K. M., et al. (1994). Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem. 269, 2632–2636 - PubMed
    1. Adeoye O., Broderick J. P. (2010). Advances in the management of intracerebral hemorrhage. Nat. Rev. Neurol. 6, 593–60110.1038/nrneurol.2010.146 - DOI - PubMed
    1. Ahmad A. S., Ahmad M., De Brum-Fernandes A. J., Doré S. (2005). Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res. 1066, 71–7710.1016/j.brainres.2005.10.068 - DOI - PubMed
    1. Ahmad A. S., Ahmad M., Maruyama T., Narumiya S., Doré S. (2010a). Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice. Age (Dordr.) 32, 271–28210.1007/s11357-010-9135-y - DOI - PMC - PubMed